Microbial engines of global change
Right now, redox cycling of the elements is happening on a genuinely global scale. These cycles are driven by the intricate electron-transfer chemistry of microbial organisms. Whether engaging in the molecular construction projects of the carbon, nitrogen or sulfur cycles or simply moving electrons to make a bioenergetic living, these smallest of creatures harness metals as cofactors to cycle and recycle the environment around us continuously.
Our symposia at the American Society for Biochemistry and Molecular Biology annual meeting — now called Discover BMB — in Seattle in March will cover several topics relating to the biochemistry and microbiology of elemental cycling, where complex metalloenzymes often are used to achieve startling transformations. Recently elucidated mechanisms, insight into how metallocofactors are harnessed to power the redox reactions of life around us, and surprising insights into the connections between metals, microbes and electrons all will be discussed.
With concerns for sustainability and a new energy economy, the microscopic world of biological chemistry has much to teach us.
Keywords: Metalloenzymes, enzyme mechanisms, microbiology, biochemistry, biogeochemistry.
Who should attend: All who are fascinated by how microorganisms shape the world around us and how the environment, in turn, shapes microbial biochemistry.
Theme song: “Electric Boogie (The Electric Slide)” by Marcia Griffiths.
This session is powered by electrons, and so are you.
Speakers
The enzymology of the carbon cycle
Jennifer Dubois (chair), Montana State University
Stephen Ragsdale, University of Michigan
Sean Elliott, Boston University
Cecilia Gomez Martinez, University of California, Berkeley
Kylie Allen, Virginia Tech
Frontiers of the nitrogen cycle
Eric Hegg (chair), Michigan State University
Yilin Hu, University of California, Irvine
Lisa Stein, University of Alberta
Akif Tezcan, University of California, San Diego
Metals, microbes and minerals
Sean Elliott (chair), Boston University
Eric Boyd, Montana State University
Jennifer Dubois, Montana State University
Jeff Gralnick, University of Minnesota
Christine Morrison, Colorado School of Mines
The complete list
Learn about all 11 symposia planned for Discover BMB 2023:- Protein Machines and Disorder
- Regulation of RNA
- Organelles, Mechanisms and Phase Properties of Cellular Quality Control
- Lipid Dynamics and Signals in Membrane and Protein Structure
- Frontiers in Carbohydrate Synthesis and Recognition
- Bias In, Bias Out in Data Science
- Cell Signaling — New Tools and Emerging Concepts
- Education and Professional Development
- Biochemistry of Elemental Cycling
- Advances in Organismal and Cellular Metabolism
- Artificial Intelligence and Machine Learning in Structural Biology, Drug Design and Systems Biology
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Differences in pili structure modulate bacterial behavior
Researchers demonstrate how small changes in the structure of hair-like protein appendages can affect the behavior of Acinetobacter bacteria.

Cholesterol regulatory genes predict liver transplant outcomes
Researchers identify a link between cholesterol-regulating genes and liver transplant success, which could improve donor screening and patient outcomes.

Lipid signatures for a rare neurological disorder
Researchers find distinct lipid patterns linked to a rare autoimmune neurological disorder, offering hope for effective targeted therapies for patients.

Disease-linked mutations disrupt protein phase behavior
Researchers find that pathogenic missense mutations are enriched threefold in phrase-separating intrinsically disordered regions of proteins.

The dual role of asprosin in chronic fatty liver disease
Researchers uncover a hormone called asprosin that may serve as a potential biomarker for the diagnosis of chronic fatty liver disease and monitoring disease progression.

Novel inhibitor targets RAS-driven cancers
Researchers in Louisville identify a small-molecule drug that blocks RALGEF signaling downstream of mutant RAS. The compound suppresses tumor growth with low toxicity, revealing a new therapeutic strategy for RAS-driven malignancies.